Ariadna Ortiz Brugués (A Ortiz-Brugués, Ariadna Ortiz-Brugues, Ariadna Ortiz-Brugués)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Randomized Controlled Trial

Top Venues

Dermatology and therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

International journal of cosmetic science

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Ling Shi, Edward Lain, Nicolas Frasson, Ariadna Ortiz Brugués, Aline Stennevin
The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing. Dermatology and therapy 14 (3) (2024)
Yu-Ling Shi, Edward Lain, Nicolas Frasson, Ariadna Ortiz Brugués, Aline Stennevin
The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing. Dermatology and therapy 14 (3) (2024)
Yu-Ling Shi, Edward Lain, Nicolas Frasson, Ariadna Ortiz Brugués, Aline Stennevin
The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing. Dermatology and therapy 14 (3) (2024)
Yu-Ling Shi, Edward Lain, Nicolas Frasson, Ariadna Ortiz Brugués, Aline Stennevin
The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing. Dermatology and therapy (2024)
Yu-Ling Shi, Edward Lain, Nicolas Frasson, Ariadna Ortiz Brugués, Aline Stennevin
The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing. Dermatology and therapy 14 (3) (2024)
Yu-Ling Shi, Edward Lain, Nicolas Frasson, Ariadna Ortiz Brugués, Aline Stennevin
The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing. Dermatology and therapy 14 (3) (2024)
Yu-Ling Shi, Edward Lain, Nicolas Frasson, Ariadna Ortiz Brugués, Aline Stennevin
Correction to: The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing. Dermatology and therapy (2024)
Yu-Ling Shi, Edward Lain, Nicolas Frasson, Ariadna Ortiz Brugués, Aline Stennevin
The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing. Dermatology and therapy 14 (3) (2024)
Saskia Ingen Housz Oro, Yannick S Elshot, Sonia Segura, Antoine Marchand, Damien Pouessel, Nicolas Kluger, Giselle de Barros Silva, Ariadna Ortiz Brugués, Marine Aubert, Carolina Saldana, Dimitrios Mavroudis, Estelle Burle, Emilie Tournier, Dimitra Koumaki, Vincent Sibaud
Skin toxicity of enfortumab vedotin: proposal of a specific management algorithm. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Ariadna Ortiz Brugués, Lara Claude Braeuer, Jean-Baptiste Grieu, Ying Zhang
Clinical studies in Chinese subjects investigating the tolerance and soothing efficacy of a cream and balm containing 4-t-butylcyclohexanol on the sensitivity of facial skin. International journal of cosmetic science (2022)
Véronique Vendrely, Ander Mayor-Ibarguren, Aline Stennevin, Ariadna Ortiz Brugués
An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study. Dermatology and therapy 12 (3) (2022)
Ariadna Ortiz Brugués, Xavier Bosch-Amate, Pablo Vargas Mora, Sara Gomez-Armayones, Priscila Giavedoni, Cristina Carrera
Dermal fillers may induce late-onset adverse skin reactions in patients under BRAF inhibitors. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (11) (2020)
Ariadna Ortiz Brugués, Vincent Sibaud, Beatrice Herbault-Barrés, Sarah Betrian, Iphigenie Korakis, Caroline De Bataille, Carlos Gomez-Roca, Joel Epstein, Emmanuelle Vigarios
Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending. The oncologist 25 (2) (2019)